2019 Adverse Reactions Labelling 
Pharmaceutical Technology
SEPTEMBER 19, 2022
The latest development is based on findings from the single-arm, open-label Phase II/III ALD-102 (Starbeam) and Phase III ALD-104 clinical trials. Mucositis, vomiting, nausea, febrile neutropenia, alopecia and reduced appetite among others were reported to be the most prevalent non-laboratory adverse reactions reported.
The Checkup by Singlecare
JUNE 23, 2023
Although not all of these side effects of gabapentin can be mitigated, it’s important to know about interactions with the medication to avoid any adverse reactions. It’s essential to read the label before you pop that pill (or oral solution) and take it as advised. When in doubt, ask your pharmacist.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Checkup by Singlecare
AUGUST 4, 2023
Double check labels, or better yet, ask your pharmacist to make sure you aren’t doubling up on diphenhydramine. Alcohol Alcohol and Benadryl have sedative functions, so you can experience adverse effects when taken together or within the same time frame. Be cautious not to consume too much when treating allergies and insomnia.
The Checkup by Singlecare
OCTOBER 12, 2023
Abilify generic | Abilify vs. aripiprazole | Cost | Off-label use | How to switch Abilify is a brand-name medication approved to treat certain mental health conditions, including the treatment for schizophrenia , bipolar disorder , and major depressive disorder. Using an approved drug for an unapproved use is called off-label use.
The Checkup by Singlecare
FEBRUARY 6, 2024
While some interactions may be mild, others may lead to serious side effects or adverse reactions. Here are some common steps to take: Check the label : Always read the drug information in the product package for potential warnings, and follow the instructions on your prescription label for the appropriate dosage.
The Checkup by Singlecare
NOVEMBER 6, 2024
of patients taking the 1 mg dose experienced an injection site reaction, such as bruising, in semaglutide’s clinical trials. And Ozempic’s label reports that only 0.2% of patients reported injection site reactions in placebo-controlled trials. In clinical trials reported on the drug’s label, 15.8% In fact, only 0.6%
The Checkup by Singlecare
DECEMBER 12, 2023
Recognition of these next-day events has led to greater caution with the drug’s use and dosing, and just as important, concerns involving side effects have called attention to drug interactions that can escalate adverse reactions.
Expert insights. Personalized for you.
98 
Let's personalize your content